At PharmaWatch, we don't have a specific position on creating a separate agency, but we do have a specific position on creating an arm's-length from government research arm through this proposal we've been supporting to collect post-marketing information about specific products.
What's really important is to put the post-marketing and the pre-approval pieces of the current Health Canada regime on more of an equal footing. We've got a terrible imbalance. All the energy is going into getting those approvals. We want more energy going into protecting public safety and looking for those early signals of problems with either efficacy or safety.